William Blair & Company’s Rein Therapeutics, Inc. Common Stock RNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$33.1K Hold
23,622
﹤0.01% 1645
2025
Q1
$41.8K Sell
23,622
-1,980
-8% -$3.51K ﹤0.01% 1609
2024
Q4
$58.9K Hold
25,602
﹤0.01% 1588
2024
Q3
$90.6K Sell
25,602
-2,445
-9% -$8.66K ﹤0.01% 1552
2024
Q2
$77.7K Sell
28,047
-250
-0.9% -$692 ﹤0.01% 1544
2024
Q1
$188K Hold
28,297
﹤0.01% 1416
2023
Q4
$86.3K Sell
28,297
-700
-2% -$2.13K ﹤0.01% 1524
2023
Q3
$44.1K Sell
28,997
-670
-2% -$1.02K ﹤0.01% 1599
2023
Q2
$53.1K Sell
29,667
-2,550
-8% -$4.57K ﹤0.01% 1590
2023
Q1
$39.9K Sell
32,217
-35,650
-53% -$44.2K ﹤0.01% 1603
2022
Q4
$161K Buy
67,867
+6,527
+11% +$15.5K ﹤0.01% 1416
2022
Q3
$254K Buy
61,340
+3,911
+7% +$16.2K ﹤0.01% 1299
2022
Q2
$299K Buy
57,429
+7,096
+14% +$36.9K ﹤0.01% 1275
2022
Q1
$516K Sell
50,333
-3,041
-6% -$31.2K ﹤0.01% 1149
2021
Q4
$601K Buy
53,374
+13,216
+33% +$149K ﹤0.01% 1145
2021
Q3
$819K Buy
40,158
+5,756
+17% +$117K ﹤0.01% 999
2021
Q2
$860K Buy
34,402
+17,122
+99% +$428K ﹤0.01% 965
2021
Q1
$494K Buy
17,280
+3,880
+29% +$111K ﹤0.01% 1127
2020
Q4
$279K Buy
13,400
+1,308
+11% +$27.2K ﹤0.01% 1304
2020
Q3
$312K Buy
12,092
+165
+1% +$4.26K ﹤0.01% 1130
2020
Q2
$281K Sell
11,927
-3,270
-22% -$77K ﹤0.01% 1123
2020
Q1
$101K Sell
15,197
-2,205
-13% -$14.7K ﹤0.01% 1306
2019
Q4
$199K Buy
17,402
+15,027
+633% +$172K ﹤0.01% 1311
2019
Q3
$32K Buy
2,375
+210
+10% +$2.83K ﹤0.01% 1495
2019
Q2
$31K Buy
2,165
+1,072
+98% +$15.4K ﹤0.01% 1542
2019
Q1
$43K Buy
+1,093
New +$43K ﹤0.01% 1489